Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 100

Results For "MEA"

1111 News Found

Aster Medcity Kochi launches Cryo-ablation procedure to tackle heart disease
Hospitals | November 05, 2021

Aster Medcity Kochi launches Cryo-ablation procedure to tackle heart disease

The process is completed with the help of a balloon at a low temperature so that other cells are undamaged and the patient can return home the next day


GlaxoSmithKline posts Q2FY22 consolidated PAT at  Rs. 204.24 Cr
News | November 01, 2021

GlaxoSmithKline posts Q2FY22 consolidated PAT at Rs. 204.24 Cr

GlaxoSmithKline Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021


Samsung Receives FDA clearance for AI algorithms detecting lung nodules in X-rays
Digitisation | November 01, 2021

Samsung Receives FDA clearance for AI algorithms detecting lung nodules in X-rays

It provides an option to automatically perform nodule detection immediately after chest X-ray imaging


Transforming Healthcare Through AI
Opinion | October 29, 2021

Transforming Healthcare Through AI


Indian Pharma Market witnesses rise in volumes and prices in September.
News | October 28, 2021

Indian Pharma Market witnesses rise in volumes and prices in September.

Acute therapies continue to report strong growth compared to chronic ones.


PM launches PM Ayushman Bharat Health Infrastructure Mission
Public Health | October 26, 2021

PM launches PM Ayushman Bharat Health Infrastructure Mission

Through the mission an entire ecosystem for services from treatment to critical research will be created in every corner of the country


Lupin enters Guinness Records highlights rise in strokes
Public Health | October 25, 2021

Lupin enters Guinness Records highlights rise in strokes

This unique record was made possible by collating hard copies of the books in a structured manner


Novartis cancer drug trial does not meet primary end points
Biotech | October 25, 2021

Novartis cancer drug trial does not meet primary end points

The company is continuing with the evaluation of canakinumab in lung cancer, and is applying findings to the overall lung cancer development plan


We plan to expand into Chennai, Hyderabad and Vijayawada: Rajinish Menon, Founder & CEO, Sukino Healthcare
interviews | October 20, 2021

We plan to expand into Chennai, Hyderabad and Vijayawada: Rajinish Menon, Founder & CEO, Sukino Healthcare

Continuum care is a concept that’s gaining acceptance in South India and Sukino Healthcare with its presence in Bangalore and Kochi has made rapid strides catering to this need. It now plans to expand to many more cities in the region. Indian Pharma Post caught up with Rajinish Menon, Founder & CEO, Sukino Healthcare who gave us an insight into the company’s operations.


FDA approves Cyltezo, the first interchangeable biosimilar to Humira
Drug Approval | October 20, 2021

FDA approves Cyltezo, the first interchangeable biosimilar to Humira

Second interchangeable biosimilar product approved by agency